Buserelin as primary therapy in advanced prostatic carcinoma (pages 2416–2419)Cary A. Presant, Mark S. Soloway, Sol S. Klioze, John W. Kosola, Alun L. Yakabow, Rafael G. Mendez, Peter S. Kennedy, Melody R. Wyres, Virginia L. Naessig, Kimball S. Ford, Charles L. Wiseman, Armand Bouzaglou, Barton Tanenbaum and Daniel Eventov
Article first published online: 28 JUN 2006 | DOI: 10.1002/1097-0142(19851115)56:10<2416::AID-CNCR2820561013>3.0.CO;2-#